Contact us to learn more










You agree to be contacted with newsletters, marketing or promotional materials and other information that may be of interest to you. You may opt-out of receiving communications from us by following the unsubscribe link or the instructions provided in any email we send. For further information on our privacy practices and commitment to protecting your privacy, please visit our Privacy Policy.


Hidden Fields












Illuminating the answers hidden in our genes

Your patients depend on you to guide them through all the genetic screening and testing options to proactively manage their health. Myriad Genetics is here to support you and your patients on that journey.

Illuminating the answers hidden in our genes

Your patients depend on you to guide them through all the genetic screening and testing options to proactively manage their health. Myriad Genetics is here to support you and your patients on that journey.

plays 'Prequel prenatal screen' videolightbox

Our tests

Foresight® Carrier Screen product signature

Foresight® Carrier Screen detects a couple’s risk of passing down serious, inheritable health conditions to their child to guide informed planning and preparation.

  • Identify the 1 in 22 couples at risk for pregnancies with serious, prevalent, or clinically-actionable inherited conditions
  • 99% detection rate across ethnicities for the vast majority of the 176 genes on our panel2
MyRisk™ product signature

MyRisk® Hereditary Cancer Test is a multi-gene panel that helps to determine a patient’s risk by evaluating a number of hereditary cancer syndromes, with focus on 11 primary cancer sites.

  • All-in-one personalized cancer risk assessment
  • Evaluates 48 genes associated with 11 different hereditary cancers
  • RiskScore® predicts a patient’s 5-year and lifetime risk of developing breast cancer
Prequel®Prenatal Screen product signature

Designed for everyone regardless of ancestry and BMI or ability to pay, the Prequel® Prenatal Screen can determine if a pregnancy is at an increased risk for a wide variety of chromosomal conditions as early as 10 weeks.

  • The only non-invasive prenatal screening (NIPS) that uses AMPLIFY™ technology
  • 99.9% result delivery on the first draw at 10 weeks1
  • Accessible and reliable for everybody, regardless of BMI, ancestry, or ability to pay

Patient stories

0

FORESIGHT PATIENT STORY

How spinal muscular atrophy (SMA) affects the Pantier Family

“The screening helped us develop a plan of action to get our child what he needed”
– Ashley Pantier, Mother and SMA carrier

0

MYRISK PATIENT STORY

Caring for your future starts with your past

Breast cancer impacted three generations of Ashley’s family. Genetic testing helped her take charge of her healthcare decisions – and her family’s future.

Recent blog posts

On International Women’s Day, We’re Embracing Equity

March 7, 2023

By Marie Mount, Sr. Director, Women's Health Marketing Today is International Women’s Day! Celebrated annually on March 8 to honor the social, econo...

Honoring those affected by rare diseases

February 27, 2023

Quick — name three diseases that affect humans. We bet you came up with some of the most well-known, such as heart disease, cancer, Alzheimer’s, and COVID-...

Myriad Genetics + Gateway Genomics – Supporting women on their pregnancy journey  

November 1, 2022

By: Melissa Gonzales - President, Women’s Health, Myriad Genetics  When the big moment comes and parents learn they are having a baby, life changes and ...